[
  {
    "ts": null,
    "headline": "Why BioNTech Stock Crushed the Market Today",
    "summary": "The company might be close to commercializing its most advanced pipeline program.",
    "url": "https://finnhub.io/api/news?id=2dc1f2b33ef5ef607a551df5f582702e5a52d66de3004737cd1f82bb820f9465",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757108488,
      "headline": "Why BioNTech Stock Crushed the Market Today",
      "id": 136653005,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The company might be close to commercializing its most advanced pipeline program.",
      "url": "https://finnhub.io/api/news?id=2dc1f2b33ef5ef607a551df5f582702e5a52d66de3004737cd1f82bb820f9465"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. stock outperforms competitors on strong trading day",
    "summary": "Pfizer Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=aa0008fa0d93e66dfd0ef73161c2a6bb49dc393364b1d13823d38b9b1b3d5302",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757090160,
      "headline": "Pfizer Inc. stock outperforms competitors on strong trading day",
      "id": 136715160,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=aa0008fa0d93e66dfd0ef73161c2a6bb49dc393364b1d13823d38b9b1b3d5302"
    }
  },
  {
    "ts": null,
    "headline": "Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.?",
    "summary": "It's unprecedented times for the Covid vaccine market, experts say. And Pfizer and Moderna remain under significant pressure.",
    "url": "https://finnhub.io/api/news?id=4caf28b49fea11b4077b5861c782e85397fabdde4a948a3f99406ba4d6a6271c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757085828,
      "headline": "Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.?",
      "id": 136648906,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "It's unprecedented times for the Covid vaccine market, experts say. And Pfizer and Moderna remain under significant pressure.",
      "url": "https://finnhub.io/api/news?id=4caf28b49fea11b4077b5861c782e85397fabdde4a948a3f99406ba4d6a6271c"
    }
  },
  {
    "ts": null,
    "headline": "Lyophilized Injectable Drugs Market Report 2025-2033 | R&D Efforts to Improve Safety and Reconstitution Time, Alongside Expanding CDMO Services and Emerging Market Contributions",
    "summary": "The global lyophilized injectable drugs market is set to grow at a 14.0% CAGR from 2025 to 2033, driven by rising demand for stable parenteral medications and expansion in oncology and infectious disease treatments. North America leads, with Asia Pacific experiencing fastest growth. Key players include Pfizer, Sanofi, and Merck.Dublin, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The \"Lyophilized Injectable Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players",
    "url": "https://finnhub.io/api/news?id=a6a45a788f14fa2a929688b7af67c84f0f222811d44466e6fe01f0cd214787cd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757069400,
      "headline": "Lyophilized Injectable Drugs Market Report 2025-2033 | R&D Efforts to Improve Safety and Reconstitution Time, Alongside Expanding CDMO Services and Emerging Market Contributions",
      "id": 136647844,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The global lyophilized injectable drugs market is set to grow at a 14.0% CAGR from 2025 to 2033, driven by rising demand for stable parenteral medications and expansion in oncology and infectious disease treatments. North America leads, with Asia Pacific experiencing fastest growth. Key players include Pfizer, Sanofi, and Merck.Dublin, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The \"Lyophilized Injectable Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players",
      "url": "https://finnhub.io/api/news?id=a6a45a788f14fa2a929688b7af67c84f0f222811d44466e6fe01f0cd214787cd"
    }
  },
  {
    "ts": null,
    "headline": "Down 34%, Should You Buy the Dip on Viking Therapeutics?",
    "summary": "Viking aims to enter the billion-dollar weight loss drug market.",
    "url": "https://finnhub.io/api/news?id=1b46c276c9a6bdd7526e0c028923cb36b72866a7c37c090cadcd299ea5b93d80",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757063400,
      "headline": "Down 34%, Should You Buy the Dip on Viking Therapeutics?",
      "id": 136647788,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Viking aims to enter the billion-dollar weight loss drug market.",
      "url": "https://finnhub.io/api/news?id=1b46c276c9a6bdd7526e0c028923cb36b72866a7c37c090cadcd299ea5b93d80"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Still A Bargain Despite Kennedy's Anti-Vaccine Attacks",
    "summary": "Pfizer Inc.'s strong Q2 2025 sales defy expectations. Discover analyst insights, growth drivers, and why it's rated Strong Buy. Click for my PFE stock update.",
    "url": "https://finnhub.io/api/news?id=d73fe54fc34318ccf1d3729ec1a04d051d9f77957ff3802476624a400c8c850d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757063226,
      "headline": "Pfizer: Still A Bargain Despite Kennedy's Anti-Vaccine Attacks",
      "id": 136647643,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304540314/image_1304540314.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer Inc.'s strong Q2 2025 sales defy expectations. Discover analyst insights, growth drivers, and why it's rated Strong Buy. Click for my PFE stock update.",
      "url": "https://finnhub.io/api/news?id=d73fe54fc34318ccf1d3729ec1a04d051d9f77957ff3802476624a400c8c850d"
    }
  }
]